? Core B Overview/Rationale: Core B was newly developed to meet the growing Program-wide need for sophisticated cancer genomics and bioinformatics support, and the continuing need for statistical support for experimental design and data analysis. The newly developed bioinformatics/cancer genomics portion of this Core adds substantial cancer genomics expertise to the Program. We have included continuing support for experimental design and statistical support core services in Core B for reasons of intellectual coherence and operational efficiency. Innovation: Core B has developed the following innovations as part of their Service Plan: ? Systematic mutation assessment by visualization, hotspot analysis and functional prediction. ? Integrated scoring of tumors and cancer subtypes for mutational investment in pathways and cancer hallmarks. ? Large graph infrastructure and implementation expertise to enable real-time association and visualization of multidimensional cancer genomics data. ? Integrated statistical support for experimental design and data analysis. Significance: Cancer genomics research is heavily dependent on data mining and computational analysis. Performing these analyses in the most effective way requires incorporating large data sets (e.g., from TCGA) as part of a substantial computational infrastructure that hosts stable and appropriate tools for analysis Program research projects focusing on AML and GBM will require an integrated approach that blends and interprets locally-generated data by the judicious choice and imaginative use of existing tools and methods. Core B has been built on this model as both an efficient and powerful way to support Program research needs. Core B Services Plan: Core B will provide the following 6 key Services to enable research Program-wide: Core Service 1 ? Mutation Assessment analyses Core Service 2 ? Association analysis Core Service 3 ? Pathway analysis Core Service 4 ? Mutational Investment analyses Core Service 5 ? Large graph analysis Core Service 6 ? Statistical support IMPACT: Core B has assembled the expertise to fully support the combined bioinformatics, cancer genomics and statistical support services needed to fully enable all Project Research Plans.
? Core B Core B provides sophisticated cancer genomics and bioinformatics support, as well as continuing statistical support for Program experimental design and data analysis. The newly developed bioinformatics/cancer genomics portions of this Core are now fully integrated into Project research and will enable the success of Project-specific and collaborative research aims.
| Davis, Luther; Zhang, Yinbo; Maizels, Nancy (2018) Assaying Repair at DNA Nicks. Methods Enzymol 601:71-89 |
| Yu, Ming; Heinzerling, Tai J; Grady, William M (2018) DNA Methylation Analysis Using Droplet Digital PCR. Methods Mol Biol 1768:363-383 |
| Knijnenburg, Theo A; Wang, Linghua; Zimmermann, Michael T et al. (2018) Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23:239-254.e6 |
| Orozco, Javier I J; Knijnenburg, Theo A; Manughian-Peter, Ayla O et al. (2018) Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun 9:4627 |
| Schmitt, Michael W; Pritchard, Justin R; Leighow, Scott M et al. (2018) Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. Clin Cancer Res 24:5321-5334 |
| Mikheev, Andrei M; Mikheeva, Svetlana A; Severs, Liza J et al. (2018) Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma. Mol Oncol 12:1188-1202 |
| Lee, Su-In; Celik, Safiye; Logsdon, Benjamin A et al. (2018) A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun 9:42 |
| Salk, Jesse J; Schmitt, Michael W; Loeb, Lawrence A (2018) Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat Rev Genet 19:269-285 |
| Kamath-Loeb, Ashwini S; Zavala-van Rankin, Diego G; Flores-Morales, Jeny et al. (2017) Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotype. Sci Rep 7:44081 |
| Oshima, Junko; Sidorova, Julia M; Monnat Jr, Raymond J (2017) Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions. Ageing Res Rev 33:105-114 |
Showing the most recent 10 out of 137 publications
